Institut Curie
Clinical trials sponsored by Institut Curie, explained in plain language.
-
BREAST CANCER BREAKTHROUGH: SURGERY MAY BE SKIPPED FOR SOME PATIENTS
Disease control Not yet recruitingThis study looks at whether women with triple-negative breast cancer who have a complete response to chemo-immunotherapy can safely avoid breast and lymph node surgery. About 150 participants will be randomly assigned to either standard care with surgery or the same care without …
Phase: NA • Sponsor: Institut Curie • Aim: Disease control
Last updated May 15, 2026 12:07 UTC
-
New scan may improve detection of childhood cancer
Diagnosis Not yet recruitingThis study tests a new imaging method (18F-MFBG PET/CT) against the current standard scan (123I-MIBG) in 30 children with relapsed or refractory neuroblastoma. The goal is to see if the new scan is as good or better at finding tumors. Participants will receive both scans within a…
Phase: PHASE2 • Sponsor: Institut Curie • Aim: Diagnosis
Last updated May 17, 2026 11:51 UTC
-
Finger prick could replace needle for breast cancer drug monitoring
Knowledge-focused Not yet recruitingThis study aims to see if a simple finger-prick blood sample can accurately measure levels of certain breast cancer drugs (CDK4/6 inhibitors) compared to standard blood draws from a vein. About 90 breast cancer patients currently taking these drugs will provide both types of samp…
Phase: NA • Sponsor: Institut Curie • Aim: Knowledge-focused
Last updated May 11, 2026 20:47 UTC